Genome Sequence Suppliers Near Australasia

Admera Health was founded as a spinout from the genetics company Genewiz in 2014 as a clinical genomics company. Now primarily a research service provider, Admera Health combines expert scientific support, advanced laboratory processes, stringent ...

Since 2006, CENTOGENE has helped physicians diagnose thousands of rare disease patients around the world. A quick and accurate diagnosis can end an odyssey of medical tests and visits to multiple medical specialists. It also helps physicians better ...

MGI Tech Co., Ltd. (referred to as MGI) is committed to building core tools and technology to lead life science through intelligent innovation. With a focus on R&D, production and sales of DNA sequencing instruments, reagents, and related products, ...

Veracyte is a pioneering genomic diagnostics company. Our tests provide trustworthy and actionable ANSWERS that improve care throughout the patient journey. We ask the right questions and provide answers that give physicians and patients a clearer ...

Ultima Genomics is a pioneering company in the genomics sector, focusing on revolutionizing genomic sequencing through innovative technology and new sequencing architecture. The company's mission is to expand the scale of omics information, thereby ...

Rady Children’s Institute for Genomic Medicine is a non-profit research organization embedded within Rady Children’s Hospital-San Diego. We pioneered a medical revolution to end the diagnostic odyssey for neonatal and pediatric rare disease. Now ...

Activen is a biotech company that has pioneered a new class of actives for the dermo-cosmetic industry. Activen scouts the genomic sequences of living organisms to find promising actives. Our research has helped us identify an untapped source of ...

Cmbio specializes in advancements in microbiome science and multi-omics research, primarily focused on human, animal, and planetary health. With a team of over 100 experts in microbiology, bioinformatics, metabolomics, molecular biology, and data ...

G3T is developing assets in cardio-metabolic, metabolic and cardiovascular diseases, such as non-alcoholic steatohepatitis (NASH), obesity, diabetes, atherosclerosis, etc. We define our assets as genetically validated drug targets. We partner with ...

Population Bio, Inc. is a privately held precision medicine company that is empowering pharmaceutical companies to develop targeted therapies and companion diagnostics faster and more cost effectively. We are accelerating the delivery of precision ...

Premas Life Sciences (PLS) is a young, dynamic, and focused organization introducing game-changing niche technologies in Genomics, Cell Biology, and Biopharma to boost innovative research and diagnostics in India. We are also the knowledge partners ...

sci2sci offers a powerful, secure, and AI-enhanced data catalog tailored for biopharma, blending semantic indexing, automatic curation, cross-system integration, and full data traceability—without disrupting existing ...

Locus is a clinical-stage biotechnology company developing precision medicines for therapeutic indications across infectious disease and inflammatory diseases. Once revolutionary, antibiotics are interfering with the effectiveness of novel, ...

We are a passionate and skilled drug discovery and development biotech team developing an innovative new class of oligonucleotide antimicrobial agents. Procarta is currently working on lead optimisation for its first product, a narrow-spectrum agent ...

Ozgene is one of the leading companies providing genetically modified mice for researchers around the world. We offer a full spectrum of pre-clinical capabilities from the development of mouse models through to breeding, characterisation and ...

SeqOne Genomics is a startup based in Montpellier in the South of France, founded in 2017. The company develops state-of-the-art genomics analysis tools for clinical applications in the fields of cancer and rare diseases. Its flagship product, ...

We are an AI-immunology platform company decoding the human immune system to discover and develop novel immunotherapies for cancer and infectious diseases. We have developed our AI-immunology core technology to deeply understand the biological ...

Day Zero Diagnostics is located in the heart of the thriving Boston Landing area. This cutting-edge innovation space brings together the area’s leading science and technology companies and provides us with access to state-of-the-art research ...

BacVax, Inc., a Delaware corporation with headquarters in Phoenix, Arizona, is developing vaccines against bacteria. BacVax holds an Exclusive Patent License Agreement to use the BVP platform in conjunction with additional patent applications ...

FYR Diagnostics is developing a powerful portfolio of biomarker detection technologies with a focus on nucleic acid amplification. Our mission is to commercialize and implement these novel technologies to enable the accelerated prediction, ...